tert-butylhydroperoxide has been researched along with 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Ju, X; Qu, J; Song, Z; Tan, Q; Wang, Y; Wu, W; Yang, X; Ying, S; Zhang, X | 1 |
1 other study(ies) available for tert-butylhydroperoxide and 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one
| Article | Year |
|---|---|
Myeloid differentiation protein 2 induced retinal ischemia reperfusion injury via upregulation of ROS through a TLR4-NOX4 pathway.
Topics: Animals; Apoptosis; Cell Survival; Chalcones; Disease Models, Animal; Ependymoglial Cells; Humans; Lymphocyte Antigen 96; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 4; Oxidative Stress; Reactive Oxygen Species; Reperfusion Injury; Retinal Diseases; Signal Transduction; tert-Butylhydroperoxide; Toll-Like Receptor 4 | 2018 |